Senores Pharmaceuticals IPO GMP, Grey Market Premium Today

Senores Pharmaceuticals IPO's GMP is ₹284 on December 30, 2024. If you add this to the IPO price, which is ₹391, you get an estimated listing price of ₹675. This means there's a potential gain of 72.6% per share.The GMP is updated daily, and recently it's been towards the lower side.Keep an eye on daily updates to see how the IPO price is trending.
Last Updated - 30 December, 2024 5:10 am
Check Live IPO GMP List 👈 |
Listed |
Senores Pharmaceuticals IPO GMP Today is - ₹284
IPO Price : | 391 Rs |
IPO GMP : | 284 Rs 👈 |
Expected Listing Price : | 391+284 = 675 Rs |
Expected IPO Gain %: | 72.6% 👈 |
Rating : | ★★★★★ |
Lot Shares: | 38 |
Lot Price: | 14,858 Rs |
Lot Expected Profit: | 10,792 Rs |
Senores Pharmaceuticals IPO Expected Profit
Number Of Lots | Lot Shares | Lot Price | Lot Profit | Lot Expected Listing |
---|---|---|---|---|
1 | 38 | 14,858 Rs | 10,792 Rs | 25,650 Rs |
2 | 76 | 29,716 Rs | 21,584 Rs | 51,300 Rs |
3 | 114 | 44,574 Rs | 32,376 Rs | 76,950 Rs |
4 | 152 | 59,432 Rs | 43,168 Rs | 1,02,600 Rs |
5 | 190 | 74,290 Rs | 53,960 Rs | 1,28,250 Rs |
6 | 228 | 89,148 Rs | 64,752 Rs | 1,53,900 Rs |
7 | 266 | 1,04,006 Rs | 75,544 Rs | 1,79,550 Rs |
8 | 304 | 1,18,864 Rs | 86,336 Rs | 2,05,200 Rs |
9 | 342 | 1,33,722 Rs | 97,128 Rs | 2,30,850 Rs |
10 | 380 | 1,48,580 Rs | 1,07,920 Rs | 2,56,500 Rs |
11 | 418 | 1,63,438 Rs | 1,18,712 Rs | 2,82,150 Rs |
12 | 456 | 1,78,296 Rs | 1,29,504 Rs | 3,07,800 Rs |
13 | 494 | 1,93,154 Rs | 1,40,296 Rs | 3,33,450 Rs |
Senores Pharmaceuticals IPO Dates
IPO Activity | Date |
---|---|
Open Date: | 20 December, 2024 |
Close Date: | 24 December, 2024 |
Allotment Date: | 26 December, 2024 |
Refund Date: | 27 December, 2024 |
Shares Credit Date: | 27 December, 2024 |
Listing Date: | 30 December, 2024 |
Senores Pharmaceuticals IPO GMP Grey Market Premium FAQs
Q.What is Senores Pharmaceuticals IPO GMP Today?
Ans.Senores Pharmaceuticals IPO GMP is ₹284 as of today.
Q.What is Senores Pharmaceuticals IPO Expected Returns?
Ans.Senores Pharmaceuticals IPO Expected Returns is 72.6%.